Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Silverback Therapeutics stock (Silverback Therapeutics)

Buy Silverback Therapeutics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Silverback Therapeutics is a biotechnology business based in the US. Silverback Therapeutics shares (SBTX) are listed on the NASDAQ and all prices are listed in US Dollars. Silverback Therapeutics employs 90 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Silverback Therapeutics Inc stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $1,000 in stock
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Silverback Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SBTX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Silverback Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $1,000 in stock
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Silverback Therapeutics stock price (NASDAQ: SBTX)

Use our graph to track the performance of SBTX stocks over time.

Silverback Therapeutics shares at a glance

Information last updated 2024-06-30.
Latest market close$0.00
52-week range$0.00 - $0.00
50-day moving average $5.39
200-day moving average $4.37
Wall St. target price$5.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.73

Is it a good time to buy Silverback Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Silverback Therapeutics price performance over time

Historical closes compared with the close of $0 from 2022-11-21

1 week (2024-07-01) nan%
1 month (2024-06-08) nan%
3 months (2024-04-08) nan%
6 months (2024-01-08) nan%
1 year (2023-07-08) nan%
2 years (2022-07-12) -100.00%
3 years (2021-07-12) 30.93
5 years (2019-07-08) N/A

Silverback Therapeutics financials

Gross profit TTM $0
Return on assets TTM -17.36%
Return on equity TTM -28.5%
Profit margin 0%
Book value $7.53
Market Capitalization $211.7 million

TTM: trailing 12 months

Silverback Therapeutics share dividends

We're not expecting Silverback Therapeutics to pay a dividend over the next 12 months.

You may also wish to consider:

Silverback Therapeutics overview

Silverback Therapeutics, Inc. , a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington. .

Frequently asked questions

What percentage of Silverback Therapeutics is owned by insiders or institutions?
Currently 1.664% of Silverback Therapeutics shares are held by insiders and 78.614% by institutions.
How many people work for Silverback Therapeutics?
Latest data suggests 90 work at Silverback Therapeutics.
When does the fiscal year end for Silverback Therapeutics?
Silverback Therapeutics's fiscal year ends in December.
Where is Silverback Therapeutics based?
Silverback Therapeutics's address is: 500 Fairview Avenue North, Seattle, WA, United States, 98109

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site